MORE AFFORDABLE CGM||
Stores up to 90 days of glucose data, so you and your patients can see patterns and historic trends
80% of FreeStyle Libre 14 day system users report that it enables them to adjust insulin doses more frequently3
92% of FreeStyle Libre 14 day system users feel it makes managing meal-time glucose easier3
Patients can fill their prescriptions at participating retail pharmacies.
A rep can keep you informed about new and existing Abbott products.
FreeStyle Libre Pro system offers many features that will make you rethink professional CGM.
*FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app. Use of the FreeStyle LibreLink app requires registration with LibreView, a service provided by Abbott and Newyu, Inc.
†LibreView is developed, distributed, and supported by Newyu, Inc. The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
‡Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.
§Calibration or coding not required by the user.
||Based on a comparison of the list price of the FreeStyle Libre 14 Day system versus competitors' CGM systems. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
¶Benefits for FreeStyle Libre 14 Day sensors apply to two 2 sensors per month. Benefits for FreeStyle Libre 14 Day reader apply to one 2 reader. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs, or residents of US territories and possessions, except Puerto Rico. For Massachusetts residents, only those patients responsible for the fulI cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary. FreeStyle Libre 14 Day system requires a prescription.
#FreeStyle LibreLink app and FreeStyle Libre 14 Day reader have similar but not identical features. Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.
**If you want to use your reader, you must start the sensor with the reader first.
††FreeStyle LibreLink app and FreeStyle Libre 14 Day reader do not share data. For complete information on a device, be sure to scan your sensor every 8 hours with that device; otherwise, your reports will not include all your data.
‡‡Use of FreeStyle LibreLink app requires registration with LibreView, a service provided by Abbott and Newyu, Inc.
References: 1. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55-73. 2. FreeStyle Libre 14 day User's Manual. 3. Fokkert M, van Dijk P, Edens M, et al. Improved
well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care. 2019;7(1):e000809. doi:10.1136/bmjdrc-2019-000809
ADC-05528 v8.0 10/20